RxDoctor Payments Data

Sarah Martin

Gerontology · Tucson, AZNPI 1700336724

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Abbott at 33.0% of the total.

$5,693in general payments, 2019–2025

Across 68 payments — averaging $83.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$1K
  • Medtronic$1K
  • Merz Pharmaceuticals, LLC$215
  • AbbVie$212
  • Teva Pharmaceuticals USA, Inc.$209
  • plus $1K from 10 others

What the payments were for

  • Travel & lodging$3,01453%
  • Food & beverage$2,67947%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,693 in reported general payments places this provider in the 85th percentile of 99 gerontology providers in Arizona.

See all gerontology providers in Arizona

Medicare billing

Part B allowed, 2024
$5,695
Medicare patients
35
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$132,398
RytaryCarbidopa/Levodopa72$72,432
GocovriAmantadine Hcl19$51,699
Carbidopa-LevodopaCarbidopa/Levodopa136$4,506
Rivastigmine26$4,304
RivastigmineRivastigmine Tartrate42$3,412
Carbidopa-Levodopa ErCarbidopa/Levodopa54$2,722
AmantadineAmantadine Hcl46$2,412
Mirtazapine36$1,284
Midodrine Hcl17$1,179
Baclofen16$1,133
Gabapentin51$917
Donepezil Hcl62$717
Clozapine30$665
Pregabalin29$617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$209$132,39812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 99 gerontology providers in Arizona.

Other gerontology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →